Baldwin Wealth Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-165
Closed -$25.7K 293
2024
Q3
$25.7K Sell
165
-284
-63% -$45.8K ﹤0.01% 660
2024
Q2
$70K Buy
449
+49
+12% +$7.37K 0.01% 299
2024
Q1
$54.2K Sell
400
-144
-26% -$19.1K ﹤0.01% 357
2023
Q4
$73.2K Sell
544
-1,390
-72% -$181K 0.01% 319
2023
Q3
$262K Hold
1,934
0.02% 199
2023
Q2
$277K Buy
1,934
+78
+4% +$11.5K 0.02% 212
2023
Q1
$258K Buy
1,856
+685
+58% +$92.2K 0.02% 217
2022
Q4
$159K Buy
1,171
+621
+113% +$77.9K 0.01% 259
2022
Q3
$61K Buy
550
+400
+267% +$50.7K 0.01% 305
2022
Q2
$20K Hold
150
﹤0.01% 471
2022
Q1
$20K Buy
+150
New +$18K ﹤0.01% 476
2019
Q3
Sell
-53
Closed -$4K 522
2019
Q2
$4K Buy
+53
New +$4.16K ﹤0.01% 472

Other funds holding AZN